TD Waterhouse Canada’s Arcadia Biosciences RKDA Stock Holding History

TD Waterhouse Canada’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50	Buy	+70	New	+$72	﹤0.01%	2342

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TD Waterhouse Canada's RKDA Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 70 shares worth $50. The stake represents ﹤0.01% of the portfolio and ranks #2342 among its holdings.

17 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

TD Waterhouse Canada held 70 shares of Arcadia Biosciences worth $50 as of Q2 2026.
Arcadia Biosciences was a new TD Waterhouse Canada position in Q2 2026.
Arcadia Biosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2342 holding.
17 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.